1.A Case of Uterine Prolapse in Pregnancy.
Yun Hyeon HWANG ; Young Seok CHO ; Yong Min KIM ; In Hyun KIM ; Chung Woong KAY ; Chung No LEE
Korean Journal of Perinatology 1999;10(4):524-527
Uterine prolapse with pregnancy is rare condition. The overall incidence is 1/10000- 15000 deliveries. The complications from uterine prolapse range from minor cervical ulceration and infection to fetal death or uterine rupture. The fetal mortality was as high as 22% mainly due to prematurity, respiratory infection. The management of this condition is focused on preventing late occurrence of prolapse during pregnancy and continued reduction. We present a case of uterine prolapse in pregnancy with a brief review of the literature.
Fetal Death
;
Fetal Mortality
;
Incidence
;
Pregnancy*
;
Prolapse
;
Ulcer
;
Uterine Prolapse*
;
Uterine Rupture
2.Efficacy of Ferritin - folate - cyanocobalamin Supplementation during Pregnancy for Prevention of Anemia.
In Hyun KIM ; You Bong SONG ; Jin Young BAEK ; Hye Sun JUN ; Jim Ho CHO ; Chung Woong KAY ; Chung No LEE
Korean Journal of Perinatology 1999;10(4):453-459
OBJECTIVE: The purpose of this study is to evaluate the efficacy of ferritin-folate-cyanocobalamin supplementation for prevention of anemia during pregnancy. METHODS: The authors conducted a clinical investigation on 50 pregnant women from 20th to 36th gestational weeks. The cobination of cyanocobalamin coenzyme 500mg, folic coenzyme 800mcg, and ferritin 20mg constituted the supplementation. The parameters examined in first trimester as baseline, before treatment(at 20th weeks), and after treatment(at 36th weeks) were : hemoglobin, hematocrit, ferritin, mean corpuscular hemoglobin(MCH), mean corpuscular hemoglobin concentration(MCHC), mean corpuscular volume(MCV), red blood cell count(RDW), folic acid, and vit. BPaired sample t-test was used for comparison. RESULTS: The results indicated a significant increase in the value of hemoglobin(p<0.05) and hematocrit(p<0.01) in comparison to before and after the treatment. The values of serum ferritin, folic acid, vitamin Bwere increased after the treatment compared to those of before the treatment, though there was no statistical significance. The results of MCV, MCH, MCHC, and RDW showed no statistically significant in comparison to before and after the treatment. CONCLUSIONS: These data indicate that supplementing ferritin 20mg-folate 800mcg-cyanocobalamine 500mcg per day from 20th to 36th weeks' gestation can increase values of hemoglobin, hematocrit, and ferritin concentration and can be cosidered as an appropriate method to prevent iron deficient anemia. It also might increase the value of folic acid and vitamin B12, concentration, but further study is stiU needed to determine whether the supplementation of folate and cyanocobalamine in combination with iron can have better eflicacy than iron alone in prevention of iron deficiency anemia.
Anemia*
;
Anemia, Iron-Deficiency
;
Erythrocyte Indices
;
Erythrocytes
;
Female
;
Ferritins*
;
Folic Acid*
;
Hematocrit
;
Humans
;
Iron
;
Pregnancy Trimester, First
;
Pregnancy*
;
Pregnant Women
;
Vitamin B 12*
;
Vitamins
3.Second trimester selective termination in a dizygotic twin pregnancy with discordancy for Down's syndrome: A case report.
Hye Sun JUN ; Suk Kyung KIM ; Joo Yun CHO ; Sook Hwan LEE ; Hye Kyung LEE ; Chung Woong KAY
Korean Journal of Obstetrics and Gynecology 2000;43(2):302-304
A 33-year-old-woman with twin pregnancy underwent genetic amniocentesis in our hospital at 16 weeks of gestation. Fetal chromosomal analysis showed 46,XY,inv(9) and 47,XX,+21. The affected twin was terminated by ultrasonographically guided intracardiac injection of 3 ml potassium chloride solution at 19 weeks of gestation. A healthy 2570 g male infant was born by cesarean section with Apgar scores of 8 and 9 at one and five minutes, respectively.
Amniocentesis
;
Cesarean Section
;
Down Syndrome*
;
Female
;
Humans
;
Infant
;
Male
;
Potassium Chloride
;
Pregnancy
;
Pregnancy Trimester, Second*
;
Pregnancy*
;
Pregnancy, Twin
;
Twins, Dizygotic*
4.Preimplantation Genetic Diagnosis.
Sook Hwan LEE ; Sung Won CHO ; Jung Hee HAN ; Kwang Eun CHA ; Chung Woong KAY ; In Pyung KWAK ; Eun Jung LEE ; Tae Ki YOON ; Kwang Yul CHA
Korean Journal of Obstetrics and Gynecology 1998;41(12):2913-2916
No abstract available.
Preimplantation Diagnosis*
5.Survival Analysis of the Children with Down Syndrome.
Jung Sun KIM ; In Kyu KIM ; Jin Seop KANG ; Eun Kyung LEE ; Bo Kyung KIM ; Kyu Hyung LEE ; Seo Jeong KIM ; Hyung Gon KANG ; Chung Woong KAY ; Hee Jung AHN
Korean Journal of Perinatology 1999;10(3):338-344
OBJECTIVE: To determine the life expectancy and causes of death of the children with Down syndrome(DS), longitudinal follow-up study was done for 29 cases of DS who were born at CHA hospital located in Seoul During the period from July 1991 to Dec. 1994. METHODS: 29 cases were divided into groups according to the presence of congenital heart disease (CHD) and leukemia. CHD group was subdivided into DS with complete AVSD(atrioventricular septal defect) and DS without complete AVSD. Survival curves were calculated by kaplan-Meier product limit method. Each group were compared by log rank test. The factors affecting mortality rate were analyzed by Cox's proportional hazard regressional model. RESULTS: There were no statistical differences in mortality rate between groups with CHD(35.3%) and without CHD(33.3%)(p=0.7373). Statistical difference was not observed between CHD subgroups with AVSD and with CHD other than AVSD. There were significant statistical difference in mortality rate between groups with leukemia and without leukemia(p=0.0001). CONCLUSION: The factor affecting mortality rate of DS was the presence of leukemia regardless of presence of CHD in our study cases with DS.
Cause of Death
;
Child*
;
Down Syndrome*
;
Follow-Up Studies
;
Heart Defects, Congenital
;
Humans
;
Kaplan-Meier Estimate
;
Leukemia
;
Life Expectancy
;
Mortality
;
Seoul
;
Survival Analysis*
6.Diagnosis of Fragile X Syndrome and DMD by using DIG System.
Sook Hwan LEE ; Sung Won CHO ; Jung Hee HAN ; Kyo Won LEE ; Kwang Eun CHA ; Se Yul HAN ; Chung Woong KAY ; Se Hyun CHO ; Ki Boong OUM ; In Pyung KWAK
Korean Journal of Obstetrics and Gynecology 1998;41(11):2849-2854
The aim of this study was to develop a rapid and safe non-radioactive DIG DNA labeling and detection for Southern blot analysis for fragile X syndrome and Duchenne muscular dystrophy (DMD). Southern blot analysis is accurate test showing expression of the (CGG)n repeat and abnormal methylation pattern of CpG island in hagile X syndrome, and good confirmative secondary test in case of deletion in DMD. But in terms of test rapidity, these conventional radioactive Southern analysis may not be feasible for rapid screening of prenatal samples and at-risk populations to determine their status and to provide genetic counseling to their families. As an alternative radioactive Southern blotting, DIG DNA labeling and detection system does not require handling of radioactive material nor require learning any new technology. The complete procedure of labeling the DNA and hybridization to detection of the first visible signal can be compbsbed witbin 7 days. In addition, hybridization solutions containing labeled DNA can be reused several times after renewed denaturation.
Blotting, Southern
;
CpG Islands
;
Diagnosis*
;
DNA
;
Fragile X Syndrome*
;
Genetic Counseling
;
Humans
;
Learning
;
Mass Screening
;
Methylation
;
Muscular Dystrophy, Duchenne
7.The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
Jin Ho SONG ; Hong Gyun WU ; Bhum Suk KEAM ; Jeong Hun HAH ; Yong Chan AHN ; Dongryul OH ; Jae Myoung NOH ; Hyo Jung PARK ; Chang Geol LEE ; Ki Chang KEUM ; Jihye CHA ; Kwan Ho CHO ; Sung Ho MOON ; Ji Yoon KIM ; Woong Ki CHUNG ; Young Taek OH ; Won Taek KIM ; Moon June CHO ; Chul Seung KAY ; Yeon Sil KIM
Cancer Research and Treatment 2016;48(3):917-927
PURPOSE: We compared the treatment results and toxicity in nasopharyngeal carcinoma (NPC) patients treated with concurrent chemotherapy (CCRT) alone (the CRT arm) or neoadjuvant chemotherapy followed by CCRT (the NCT arm). MATERIALS AND METHODS: A multi-institutional retrospective study was conducted to review NPC patterns of care and treatment outcome. Data of 568 NPC patients treated by CCRT alone or by neoadjuvant chemotherapy followed by CCRT were collected from 15 institutions. Patients in both treatment arms were matched using the propensity score matching method, and the clinical outcomes were analyzed. RESULTS: After matching, 300 patients (150 patients in each group) were selected for analysis. Higher 5-year locoregional failure-free survival was observed in the CRT arm (85% vs. 72%, p=0.014). No significant differences in distant failure-free survival (DFFS), disease-free survival (DFS), and overall survival were observed between groups. In subgroup analysis, the NCT arm showed superior DFFS and DFS in stage IV patients younger than 60 years. No significant difference in compliance and toxicity was observed between groups, except the radiation therapy duration was slightly shorter in the CRT arm (50.0 days vs. 53.9 days, p=0.018). CONCLUSION: This study did not show the superiority of NCT followed by CCRT over CCRT alone. Because NCT could increase the risk of locoregional recurrences, it can only be considered in selected young patients with advanced stage IV disease. The role of NCT remains to be defined and should not be viewed as the standard of care.
Arm
;
Chemoradiotherapy
;
Compliance
;
Disease-Free Survival
;
Drug Therapy*
;
Humans
;
Induction Chemotherapy
;
Methods
;
Nasopharyngeal Neoplasms
;
Propensity Score*
;
Radiotherapy
;
Recurrence
;
Republic of Korea
;
Retrospective Studies*
;
Standard of Care
;
Treatment Outcome
8.Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea.
Soo Yoon SUNG ; Min Kyu KANG ; Chul Seung KAY ; Ki Chang KEUM ; Sung Hwan KIM ; Yeon Sil KIM ; Won Taek KIM ; Ji Yoon KIM ; Jin Hee KIM ; Sung Ho MOON ; Yong Chan AHN ; Young Taek OH ; Hong Gyun WU ; Chang Geol LEE ; Woong Ki CHUNG ; Kwan Ho CHO ; Moon June CHO ; Jin Hwa CHOI
Radiation Oncology Journal 2015;33(3):188-197
PURPOSE: To investigate the patterns of care for patients with nasopharyngeal carcinoma (NPC) in South Korea. MATERIALS AND METHODS: A multi-institutional retrospective study was performed (Korean Radiation Oncology Group [KROG] 11-06) on a total of 1,445 patients from 15 institutions. RESULTS: Of the 1,445 patients, more than half were stages III (39.9%) and IV (35.8%). In addition to patterns of care, we also investigated trends over time with the periods 1988-1993, 1994-2002, and 2003-2011. The frequencies of magnetic resonance imaging and positron emission tomography-computed tomography were markedly increased in the third period compared to previous 2 periods. Concurrent chemoradiation (CCRT) was performed on 894 patients (61.9%), neoadjuvant chemotherapy on 468 patients (32.4%), and adjuvant chemotherapy on 366 patients (25.3%). Of stage II-IV patients, CCRT performed on 78.8% in 2003-2011 compared to 15.0% in 1988-1993. For patients treated with CCRT, cisplatin was the most commonly used agent in 81.3% of patients. Over the periods of time, commonly used radiotherapy (RT) techniques were changed from 2-dimensional RT (1988-1993, 92.5%) to 3-dimensional RT (2003-2011, 35.5%) or intensity-modulated RT (IMRT; 2003-2011, 56.5%). Median RT doses given to primary tumors, high-risk lymphatics, and low-risk lymphatics were 70.0 Gy, 58.1 Gy, and 48.0 Gy, respectively. Adoption of IMRT increased the dose per fraction and escalated total radiation dose. CONCLUSION: Assessment of the patterns of care for NPC patients in South Korea demonstrated that management for NPC including diagnostic imaging, treatment regimen, RT techniques and dose schedule, advanced in accordance with the international guidelines.
Appointments and Schedules
;
Chemotherapy, Adjuvant
;
Cisplatin
;
Diagnostic Imaging
;
Drug Therapy
;
Electrons
;
Humans
;
Korea*
;
Magnetic Resonance Imaging
;
Nasopharyngeal Neoplasms
;
Radiation Oncology
;
Radiotherapy
;
Retrospective Studies